Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients

Christopher R. deFilippi*, DuWayne L. Willett, M. Elizabeth Brickner, Christopher P. Appleton, Clyde W. Yancy, Eric J. Eichhorn, Paul A. Grayburn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

300 Scopus citations

Abstract

The safety of dobutamine echocardiography in coronary artery disease is well established.27 This study shows that dobutamine can be given safely to patients with AS during noninvasive hemodynamic monitoring. The small number of patients in this study preclude assessment of the effect of dobutamine echocardiography on outcome. A large prospective study is indicated. Although the continuity equation does not contain a flow-dependent constant, its limitations include underestimation of LV outflow diameter and failure to properly align the Doppler beam.18 However, even if errors in velocity measurement occurred, directional changes should be valid since the transducer locations were identical at baseline and dobutamine infusion.

Original languageEnglish (US)
Pages (from-to)191-194
Number of pages4
JournalThe American journal of cardiology
Volume75
Issue number2
DOIs
StatePublished - Jan 15 1995

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients'. Together they form a unique fingerprint.

Cite this